| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,861 |
6,108 |
$394K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
4,476 |
3,598 |
$138K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,359 |
1,299 |
$132K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,259 |
1,254 |
$105K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,230 |
1,228 |
$103K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,360 |
1,297 |
$70K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
721 |
721 |
$65K |
| 90461 |
|
918 |
916 |
$39K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
4,237 |
4,231 |
$38K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
449 |
444 |
$35K |
| 99173 |
|
1,039 |
1,038 |
$23K |
| 96127 |
|
2,187 |
2,184 |
$22K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
2,084 |
2,081 |
$22K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
854 |
820 |
$21K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,501 |
1,460 |
$19K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
796 |
773 |
$10K |
| 83655 |
|
489 |
484 |
$6K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
161 |
159 |
$6K |
| 92551 |
|
563 |
562 |
$5K |
| 85018 |
|
1,240 |
1,238 |
$3K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
65 |
61 |
$2K |
| 92552 |
|
69 |
69 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
72 |
72 |
$1K |
| 81002 |
|
517 |
504 |
$1K |
| 80061 |
Lipid panel |
82 |
82 |
$1K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
13 |
13 |
$1K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
28 |
28 |
$427.28 |
| 99442 |
|
14 |
14 |
$291.34 |
| 87807 |
|
25 |
25 |
$282.56 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
29 |
29 |
$34.50 |